James Foy, co-founder of Hudson River Capital Partners, invests in early-stage companies within the health technology. See sector focus and contact routes.
James Foy, co-founder of Hudson River Capital Partners, invests in early-stage companies within the health technology, healthcare, life sciences, and technology sectors in the United States. The firm’s distinctive thesis targets businesses that add value to the healthcare system and possess potential for financial success, with a focus on both healthcare services and products. His latest known portfolio investment was in Vytalize, a clinics/outpatient services company, in January 2020. Specific check sizes are not publicly disclosed in available sources.
StartupFundraising tracks this investor record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in Irvington.
Investors like James Foy · Full investor directory · Investor access · Company funding database